Tayag Ngochua & Chu is a corporate and commercial law firm established in 2022. The firm advises on mergers and acquisitions, joint ventures, foreign investments, banking, fintech and competition matters. From its initial two-lawyer team, the firm has expanded to eight lawyers operating from its Bonifacio Global City office. In 2024, the firm formed a strategic alliance with Mori Hamada as their Philippine member firm, enhancing its cross-border capabilities across Asia Pacific.
Client feedback
“The firm stands out for the quality of its legal advice and output, the thoroughness of the legal reviews they conduct, the timeliness of their deliverables, and the competitive prices and fees that they charge.” – Corporate and M&A
“Responsive, knowledgeable and efficient.” – Corporate and M&A
Carlos Tayag
“Carlos is a terrific lawyer and is very commercial. The solutions and approaches that he proposes are very practical, without sacrificing the quality of the output that is necessary. He is a strong communicator that can very clearly articulate issues and solutions and is very client-friendly.”
Work highlights
Advised KV Asia Capital on its $15 million investment for a 25% stake in Wildflour Hospitality Group, marking the private equity firm's first Philippine transaction. The deal values the premium casual dining group at $60 million and supports its expansion plans across Metro Manila, with 10 new outlets planned following successful openings at three locations including NAIA Terminal 1.
Advised Nihon Kolmar Group on Philippine aspects of its acquisition of Tokiwa Cosmetics Group from The Carlyle Group. The transaction united Japan's largest contract cosmetics manufacturer with a leading global producer supplying top makeup brands, including its Philippine subsidiary Tokiwa Subic Corporation, which plays a strategic role in the group's regional supply chain operations.
Represented Robinsons Retail Holdings in the Philippine Competition Commission's motu proprio review of its completed acquisition of Rose Pharmacy. The transaction involved South Star Drug's purchase of 100% stake in Rose Pharmacy, combining two major pharmaceutical retail chains. Following an 11-month review - only the second such retrospective investigation in PCC's history - the Commission terminated its inquiry without imposing conditions, establishing a significant precedent for post-completion competition assessments in the Philippines based on actual market data rather than theoretical harm analysis.
Key clients
AHCHI Pharma Ventures, Shimizu Corporation
